SEC Form 4/A · accession 0001638599-17-000690
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Lloyd P. Johnston
Officer — COO and SVP, R&D
Period of report
Jun 15, 2017
Accepted (ET)
Jul 10, 2017 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2017 | M | 10,512 | $0.47 | A | 12,118 | D | |
| Common StockF1,F3 | Jun 15, 2017 | S | 10,512 | $17.0416 | D | 1,606 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F4 | $0.47 | Jun 15, 2017 | M | 10,512 | D | — | Jul 23, 2019 | Common Stock | 10,512 | 10,000 | D |
Explanation of responses
- F1On June 19, 2017, the reporting person filed a Form 4 reporting the June 15, 2017 exercise and sale of 20,512 shares of common stock pursuant to a 10b5-1 plan. The reporting person's broker subsequently acknowledged that 10,000 of such 20,512 shares were erroneously exercised and sold by the broker. The exercise and sale of the 10,000 shares was unwound through the broker's error account and therefore did not occur for purposes of the reporting person's account. This Form 4 amends and restates, in their entirety, the transactions reported in the June 19, 2017 Form 4.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.10, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- F4All shares underlying this option are fully vested.